LARIAT RS
Device
AtriCure, Inc.
Total Payments
$529,291
Transactions
343
Doctors
51
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $78,463 | 45 | 20 |
| 2023 | $191,384 | 129 | 11 |
| 2022 | $259,444 | 169 | 25 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $433,740 | 235 | 81.9% |
| Consulting Fee | $83,588 | 27 | 15.8% |
| Travel and Lodging | $8,090 | 19 | 1.5% |
| Food and Beverage | $3,873 | 62 | 0.7% |
Payments by Type
Research
$433,740
235 transactions
General
$95,550
108 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION | ATRICURE, INC. | $185,169 | 0 |
| NONRANDOMIZED MULTICENTER EXPANDED USE EVALUATION OF THE LARIAT SUTURE DELIVERY DEVICE APPENDIX 16 TO ONGOING INVESTIGATION | ATRICURE, INC. | $184,259 | 0 |
| NON-RANDOMIZED, MULTICENTER EXPANDED USE EVALUATION OF THE LARIAT SUTURE DELIVERY DEVICE (APPENDIX 16 TO ONGOING INVESTIGATION) | ATRICURE, INC. | $60,908 | 0 |
| NON-RANDOMIZED, MULTICENTER EXPANDED USE EVALUATION OF THE LARIAT SUTURE DELIVERY DEVICE (APPENDIX 16 TO ONGOING INVESTIGATION) | AtriCure, Inc. | $2,729 | 0 |
| NONRANDOMIZED MULTICENTER EXPANDED USE EVALUATION OF THE LARIAT SUTURE DELIVERY DEVICE APPENDIX 16 TO ONGOING INVESTIGATION | AtriCure, Inc. | $675.00 | 0 |
Top Doctors Receiving Payments for LARIAT RS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Houma, LA | $433,740 | 235 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Saint Helena, CA | $37,500 | 8 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Kansas City, MO | $8,000 | 1 |
| , MD | Cardiovascular Disease | Houma, LA | $7,500 | 2 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Los Angeles, CA | $6,999 | 4 |
| , MD | Cardiovascular Disease | Louisville, KY | $5,713 | 2 |
| , M.D | Internal Medicine | Nashville, TN | $5,625 | 2 |
| , MD | Cardiovascular Disease | Austin, TX | $3,121 | 2 |
| , MD | Cardiovascular Disease | Kansas City, KS | $3,002 | 20 |
| , PA-C | Medical | Tavares, FL | $2,124 | 2 |
| , M.D | Internal Medicine | Atlantis, FL | $1,800 | 4 |
| , MD | Internal Medicine | Maywood, IL | $1,612 | 8 |
| , MD | Cardiovascular Disease | Bryn Mawr, PA | $1,410 | 3 |
| , MD | Cardiovascular Disease | Houston, TX | $1,407 | 4 |
| , MD | Cardiovascular Disease | Houston, TX | $1,291 | 2 |
| , MD | Cardiovascular Disease | Austin, TX | $1,291 | 2 |
| , M.D | Surgery | Cincinnati, OH | $1,250 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Louisville, KY | $1,213 | 1 |
| , M.D | Cardiovascular Disease | Lexington, KY | $1,213 | 1 |
| , M.D | Surgery | Cincinnati, OH | $1,213 | 1 |
| , PA, ATC | Physician Assistant | Fort Pierce, FL | $562.50 | 1 |
| , M.D | Cardiovascular Disease | West Des Moines, IA | $175.85 | 2 |
| , M.D | Surgery | Des Moines, IA | $175.85 | 2 |
| , M.D | Clinical Cardiac Electrophysiology | Boston, MA | $129.49 | 1 |
| , MD | Internal Medicine | West Hollywood, CA | $129.19 | 1 |
Ad
Manufacturing Companies
- ATRICURE, INC. $508,947
- AtriCure, Inc. $20,344
Product Information
- Type Device
- Total Payments $529,291
- Total Doctors 51
- Transactions 343
About LARIAT RS
LARIAT RS is a device associated with $529,291 in payments to 51 healthcare providers, recorded across 343 transactions in the CMS Open Payments database. The primary manufacturer is AtriCure, Inc..
Payment data is available from 2022 to 2024. In 2024, $78,463 was paid across 45 transactions to 20 doctors.
The most common payment nature for LARIAT RS is "Unspecified" ($433,740, 81.9% of total).
LARIAT RS is associated with 5 research studies, including "LEFT ATRIAL APPENDAGE LIGATION WITH THE LARIAT SUTURE DELIVERY SYSTEM AS ADJUNCTIVE THERAPY TO PULMONARY VEIN ISOLATION FOR PERSISTENT OR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION" ($185,169).